Un sym m etr ica l Dia r yl Su lfon es a n d Ar yl Vin yl Su lfon es th r ou gh
P a lla d iu m -Ca ta lyzed Cou p lin g of Ar yl a n d Vin yl Ha lid es or
Tr ifla tes w ith Su lfin ic Acid Sa lts
Sandro Cacchi,*,† Giancarlo Fabrizi,† Antonella Goggiamani,† Luca M. Parisi,† and
Roberta Bernini‡
Dipartimento di Studi di Chimica e Tecnologia delle Sostanze Biologicamente Attive, Universita` degli
Studi “La Sapienza”, P. le A. Moro 5, 00185 Rome, Italy, and Dipartimento A.B.A.C., Universita` degli
Studi della Tuscia, Via S. Camillo De Lellis, 01100 Viterbo, Italy
sandro.cacchi@uniroma1.it
Received April 19, 2004
The palladium-catalyzed reaction of sulfinic acid salts with a wide variety of aryl and vinyl halides
or triflates provides unsymmetrical diaryl sulfones and aryl vinyl sulfones in good to excellent
yields. The reaction is strongly influenced by the presence of nBu4NCl, and the use of Xantphos, a
rigid bidentate ligand with a wide natural bite angle, was found to be crucial for the success of the
reaction. With neutral, electron-rich, and electron-poor aryl iodides best results were obtained by
n
using Pd2(dba)3, Xantphos, Cs2CO3, and Bu4NCl, in toluene at 80 °C. Two general procedures were
employed with aryl bromides and triflates: sodium p-toluenesulfinate, Pd2(dba)3, Xantphos, Cs2-
CO3, 120 °C, in toluene with nBu4NCl (procedure A: neutral, electron-rich, and slightly electron-
n
poor aryl bromides or triflates) and without Bu4NCl (procedure B: electron-poor aryl bromides or
n
triflates). With vinyl triflates best results were obtained at 60 °C omitting Bu4NCl.
In tr od u ction
HIV-1 reverse transcriptase and to represent an emerg-
ing class of substances able to address the toxicity and
resistance problems of nucleoside inhibitors. They also
exhibit interesting chemical properties6 and are useful
intermediates in organic synthesis.7 Because of this,
diaryl sulfones are important synthetic targets, and
The aryl sulfone fragment is present in a number of
compounds exhibiting important biological activities. For
example, sulfone derivatives were found to be potent,
selective, and orally active cyclooxygenase-2 (COX-2)
inhibitors1 and to exhibit high antifungal and antibac-
terial activities.2 Diaryl sulfones have been shown to
possess antitumor activities.3 Recently, diaryl4 and aryl
heteroaryl5 sulfones have been shown to inhibit the
(3) (a) J ones, T. R.; Webber, S. E.; Varney, M. D.; Reddy, M. R.;
Lewis, K. K.; Kathardekar, V.; Mazdiyasni, H.; Deal, J .; Nguyen, D.;
Welsh, K. M.; Webber, S.; J ohnson, A.; Matthews, D. A.; Smith, W.
W.; J anson, C. A.; Bacquet, R. J .; Howland, E. F.; Booth, C. L. J .; Ward,
R. W.; Herrmann, S. M.; White, J .; Bartlett, C. A.; Morse, C. A. J . Med.
Chem. 1997, 40, 677. (b) Dinsmore, C. J .; Williams, T. M.; O’Neill, T.
J .; Liu, D.; Rands, E.; Culberson, J . C.; Lobell, R. B.; Koblan, K. S.;
Kohl, N. E.; Gibbs, J . B.; Oliff, A. I.; Graham, S. L.; Hartman, G. D.
Biorg. Med. Chem. Lett. 1999, 9, 3301.
(4) (a) McMahon. J . B.; Gulakowsky, R. J .; Welslow, O. S.; Schoktz,
R. J .; Narayanan, V. L.; Clanton, D. J .; Pedemonte, R.; Wassmundt,
F. W.; Buckheit, R. W., J r.; Decker, W. D.; White, E. L.; Bader, J . P.;
Boyd, M. R. Antimicrob. Agents Chemother. 1993, 37, 754. (b) Williams,
T. M.; Ciccarone, T. M.; MacTough, S. C.; Rooney, C. S.; Balani, S. K.;
Condra, J . H.; Emini, E. A.; Goldman, M. E.; Greenlee, W. J .;
Kauffman, L. R.; O’Bnen, J . A.; Sardana, V. V.; Schleif, W. A.;
Theoharides, A. D.; Anderson, P. S. J . Med. Chem. 1993, 36, 1291. (c)
Neamati, N.; Mazumder, A.; Zhao, H.; Sunder, S.; Burke, Terrence,
R., J r.; Schultz, R. J .; Pommier, Y. Antimicrob. Agents Ch. 1997, 41,
385.
(5) (a) Artico, M.; Silvestri, R.; Massa, S.; Loi, A. G.; Corrias, S.;
Piras, G.; La Colla, P. J . Med. Chem. 1996, 39, 522. (b) Artico, M.;
Silvestri, R.; Pagnozzi, E.; Bruno, B.; Novellino, E.; Greco, G.; Massa,
S.; Ettorre, A.; Loi, A. G.; Scintu, F.; La Colla, P. J . Med. Chem. 2000,
43, 1886.
(6) (a) Fumio, H.; Mitsuru, K. J P Patent 61271271, 1986; Chem.
Abstr. 1987, 106, 213572. (b) Keiichi, S.; Toru, O.; Aki, S. J P Patent
04120050, 1992; Chem. Abstr. 1992, 117, 150703. (c) Mitchell, M. A.;
Tomida, M.; Padias, A. B.; Hall, H. K., J r.; Lackritz, H. S.; Robello, D.
R.; Willand, C. S.; Williams, D. J . Chem. Mater. 1993, 5, 1044. (d)
Toshiaki, T.; Takeshi Y. J P Patent 2001260544, 2001; Chem. Abstr.
2001, 135, 264604.
† Universita` degli Studi “La Sapienza”.
‡ Universita` degli Studi della Tuscia.
(1) (a) Ducharme, Y.; Gauthier, J . Y.; Prasit, P.; Leblanc, Y.; Wang,
Z.; Leger, S.; Therien, M. US 5474995; Chem. Abstr. 1995, 124, 201998.
(b) Ducharme, Y.; Gauthier, J . Y.; Prasit, P.; Leblanc, Y.; Wang, Z.;
Leger, S.; Therien, M. WO 9500501, 1995; Chem. Abstr. 1995, 124,
55954. (c) Prasit, P.; Wang, Z.; Brideau, C.; Chan, C.-C.; Charleson,
S.; Cromlish, W.; Ethier, D.; Evans, J . F.; Ford-Hutchinson, W.;
Gauthier, J . Y.; Gordon, R.; Guay, J .; Gresser, M.; Kargman, S.;
Kennedy, B.; Leblanc, Y.; Le´ger, S.; Mancini, J .; O’Neill, G. P.; Ouellet,
M.; Percival, M. D.; Perrier, H.; Riendeau, D.; Rodger, I.; Tagari, P.;
The´rien, M.; Vockers, P.; Wong, E.; Xu, L.-J .; Young, R. N.; Zamboni,
R.; Boyce, S.; Rupniak, N.; Forrest, M.; Visco, D.; Patrick, D. Bioorg.
Med. Chem. Lett. 1999, 9, 1773. (d) Catella-Lawson, F.; Mcadam, B.;
Morrison, B. W.; Kapoor, S.; Kujubu, D.; Antes, L.; Lasseter, K. C.;
Quan, H.; Gertz, B. J .; Fitzgerald, G. A. J . Pharmacol. Exp. Ther. 1999,
289, 735. (e) Ehrich, E. W.; Dallob, A.; De Lepeleire, I.; Van Hecken,
A.; Riendeau, D.; Yuan, W.; Porras, A.; Wittreich, J .; Seibold, J . R.;
De Schepper, P.; Mehlisch, D. R.; Gertz, B. J . Clin. Pharmacol. Ther.
1999, 65, 336. (f) Langman, M. J .; J ensen, D. M.; Watson, D. J .; Harper,
S. E.; Zhao, P.-L.; Quan, H.; Bolognese, J . A.; Simon, T. J . J . Am. Med.
Assoc. 1999, 282, 1929.
(2) (a) Richards, I. C.; Thomas, P. S. Pestic. Sci. 1990, 30, 275. (b)
Wolf, W. M. J . Mol. Struct. 1999, 474, 113. (c) Otzen, T.; Wempe, E.
G.; Kunz, B.; Bartels, R.; Lehwark-Yvetot, G.; Ha¨nsel, W.; Schaper,
K.-J .; Seydel, J . K. J . Med. Chem. 2004, 47, 240. See also: The Merck
Index, 13th ed.; Merck: Rahway, NJ ; Monograph nos. 23, 24, 75, 2847,
3013, 3365, 4476, 7015, 7236, 8785, 8962, 9013, 9014, 9058, 9079, 9273,
on CD-ROM.
(7) Simpkins, N. S. Sulfones in Organic Synthesis; Pergamon
Press: Oxford, 1993.
10.1021/jo0493469 CCC: $27.50 © 2004 American Chemical Society
Published on Web 07/16/2004
5608
J . Org. Chem. 2004, 69, 5608-5614